(Reuters) - The medical device maker said on Thursday it decided to
retain its endosurgery business after looking into selling a
minority stake through an initial public offering. For details,
see [ID:nN02444446]
Saddled with debt after its $27 billion acquisition of
Guidant Corp and hampered by slowing sales of its most
lucrative heart devices, the company said in March it was
exploring the partial sale for more than $1 billion.
Read more at Reuters.com Bonds News
retain its endosurgery business after looking into selling a
minority stake through an initial public offering. For details,
see [ID:nN02444446]
Saddled with debt after its $27 billion acquisition of
Guidant Corp and hampered by slowing sales of its most
lucrative heart devices, the company said in March it was
exploring the partial sale for more than $1 billion.
Read more at Reuters.com Bonds News
No comments:
Post a Comment